DRG Nerve Stimulant Device

Abbott Company, USA is releasing a nerve stimulation system Proclaim DRG (Dorsal Root Ganglion) to combat chronic pain in patients with complex pain syndrome in the legs. The device includes an implant called an implantable neuromodulator that stimulates the back root ganglia (DRG), an Apple iPad for programming, and an iPod Touch to control the patient. In a recent clinical trial, DRG stimulation gave significantly better results than spinal stimulation in many patients with chronic pain in the lower extremities.

Bluetooth is used to change settings on implants and to control how many stimuli are administered. The implant software board can also be updated wirelessly.

Compared to Abbott Company's first DRG neural-stimulating device, the new Axium - the new Proclaim DRG implant has a longer battery life, allowing it to be used continuously without changing the battery. As a compatible pacemaker, patients wearing Proclaim DRG implants can still perform magnetic resonance imaging (up to 1.5 Tesla), as long as precautions are taken.

Mr. Timothy Deer, Doctor of Interventional Pain Relief, CEO and President of the Virginias Spinal & Nerve Center in Charleston, West Virginia, USA - who studied the device said: " Both clinical and real-world data show that DRG stimulation provides long-term and significant relief for patients with complex regional pain syndromes - such as post-knee pain symptoms, leg surgery or disc herniation surgery ". "The ability to stimulate DRG on a Proclaim platform is a very interesting progress for all physicians treating debilitated patients who want to alleviate the pain of this difficult neuropathy. "

Source:

Translation: Dr. Nguyễn Hữu Tùng & partner